The Evaluation of Multiple Surrogate Endpoints
From MaRDI portal
Recommendations
- The evaluation of surrogate endpoints.
- Evaluating Candidate Principal Surrogate Endpoints
- Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
- A perspective on surrogate endpoints in controlled clinical trials
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
Cites work
- A Joint Model for Survival and Longitudinal Data Measured with Error
- A Stochastic Model for Censored-Survival Data in the Presence of an Auxiliary Variable
- Correcting for non-compliance in randomized trials using rank preserving structural failure time models
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
- Estimation and Comparison of Changes in the Presence of Informative Right Censoring by Modeling the Censoring Process
- scientific article; zbMATH DE number 3945130 (Why is no real title available?)
- Informative Drop-Out in Longitudinal Data Analysis
- Joint Analysis of Longitudinal Data Comprising Repeated Measures and Times to Events
- Latent Variable Models with Fixed Effects
- Marginal Regression for Repeated Binary Data with Outcome Subject to Non- Ignorable Non-Response
- Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS
- Multivariate Logistic Models for Incomplete Binary Responses
- On meta-analytic assessment of surrogate outcomes
- Random-Effects Models for Longitudinal Data
- The validation of surrogate endpoints in meta-analyses of randomized experiments
Cited in
(46)- Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS
- Incomplete multiresponse designs and surrogate endpoints in clinical trials
- Semiparametric Bayesian joint models of multivariate longitudinal and survival data
- Penalized likelihood approach for simultaneous analysis of survival time and binary longitudinal outcome
- Joint modeling of survival time and longitudinal outcomes with flexible random effects
- A new joint model for longitudinal and survival data with a cure fraction
- An efficient algorithm to assess multivariate surrogate endpoints in a causal inference framework
- Bias reduction using surrogate endpoints as auxiliary variables
- Asymptotic results for maximum likelihood estimators in joint analysis of repeated measurements and survival time
- Simplified modeling strategies for surrogate validation with multivariate failure-time data
- An overview of semiparametric models in survival analysis
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
- Simultaneous modelling of survival and longitudinal data with an application to repeated quality of life measures
- A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome
- Comparing biomarkers as principal surrogate endpoints
- Bayesian latent variable models for median regression on multiple outcomes
- Bayesian approaches to joint cure-rate and longitudinal models with applications to cancer vaccine trials
- Assessing importance of biomarkers: A Bayesian joint modelling approach of longitudinal and survival data with semi-competing risks
- Diagnostics for Joint Longitudinal and Dropout Time Modeling
- Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach
- Evaluating Candidate Principal Surrogate Endpoints
- Semiparametric Modeling of Longitudinal Measurements and Time‐to‐Event Data–A Two‐Stage Regression Calibration Approach
- On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm
- scientific article; zbMATH DE number 15221 (Why is no real title available?)
- Using surrogate failure time data to increase cost effectiveness in clinical trials
- Analyzing survival data in conjunction with time-dependent surrogate endpoints in clinical trials
- Information Recovery in a Study With Surrogate Endpoints
- Bayesian influence measures for joint models for longitudinal and survival data
- Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes
- Validation of surrogate markers in multiple randomized clinical trials with repeated measurements
- Evaluation of multivariate surveillance
- Generalized shared-parameter models and missingness at random
- Joint Models for Multivariate Longitudinal and Multivariate Survival Data
- Estimating Percentile-Specific Treatment Effects in Counterfactual Models: A Case-Study of Micronutrient Supplementation, Birth Weight and Infant Mortality
- The analysis of student paths at the university using the multivariate joint models
- Evaluating multiple surrogate markers with censored data
- Robust Approach to Combining Multiple Markers to Improve Surrogacy
- Bayesian design of clinical trials using joint cure rate models for longitudinal and time-to-event data
- An approach for jointly modeling multivariate longitudinal measurements and discrete time-to-event data
- Joint modeling of multistate and nonparametric multivariate longitudinal data
- Surrogate marker evaluation: a tutorial using R
- Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials
- Robust estimation of the proportion of treatment effect explained by surrogate marker information
- Bayesian meta-analytical methods to incorporate multiple surrogate endpoints in drug development process
- Analysis of longitudinal and survival data: joint modeling, inference methods, and issues
- Using earlier measures in a longitudinal sequence as a potential surrogate for a later one
This page was built for publication: The Evaluation of Multiple Surrogate Endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3078684)
